글로벌 위험 기반 모니터링 소프트웨어 시장 – 2029년까지의 산업 동향 및 예측

위험 기반 모니터링 소프트웨어 시장 분석 및 규모

위험 기반 모니터링 소프트웨어 시장은 위험 기반 모니터링 소프트웨어의 시간 및 비용 효율성으로 인해 향후 몇 년 동안 성장할 것으로 예상됩니다. 위험 기반 모니터링 소프트웨어는 임상 팀에 임상 프로그램 및 연구를 지원하기 위한 실행 가능한 데이터 세트에 대한 액세스를 제공합니다. 정부와 규제 기관은 오류와 실수를 피하기 위해 임상 시험을 검토하는 것의 중요성을 의무화합니다. 새로운 질병의 발견과 증가하는 수의 임상 시험 및 연구는 시장 평가에 대한 더 높은 성장 경로를 나타냅니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 위험 기반 모니터링 소프트웨어 시장의 성장을 분석합니다. 글로벌 위험 기반 모니터링 소프트웨어 시장의 예상 CAGR은 언급된 예측 기간 동안 약 13.7%인 경향이 있습니다. 이 시장은 2021년에 2억 7,800만 달러로 평가되었으며 2029년까지 7억 7,648만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

위험 기반 모니터링 소프트웨어 시장 범위 및 세분화

Market Definition

Risk-based monitoring software is clinical trial monitoring software that meets regulatory requirements. However, it is far from patient data's source data validation (SDV). Identify signals using a variety of platforms, tools, and dashboards used to resolve issues related to clinical trial safety, data integrity, and compliance. This risk-based monitoring software helps you focus on risk-free research on high-value tasks. Thus, with the onset of this software, the market will be beneficial. Hence, it is helpful for market growth.

Global Risk-Based Monitoring Software Market Dynamics

Drivers

• Increasing Demand for Web-Based Delivery Mode

The web-based (on-demand) segment is expected to hold a large market share in the risk-based monitoring software industry. This growth is due to the increasing implementation of web-based risk-based monitoring solutions due to increased scalability, reduced maintenance costs, customizability, and ease of integration. In addition, the web-based delivery mode is expected to contribute to productivity improvement and work efficiency improvement, further supporting the growth of the market. These factors are expected to contribute to overall market growth during the forecast period. Thus, it helps drive risk-based monitoring software market growth.

• Increasing Demand For Clinical Trials

The rising surge in clinical trials is a driving factor that leads to market growth. This is due to the ongoing demand for drug development amid a rise in the incidence of chronic diseases. For instance, in April 2021, Veeva Systems announced a collaboration with Parexel to leverage innovation to accelerate clinical trials. Through this partnership, Parexel will standardize Veeva's suite of clinical applications while gaining early access to Veeva's clinical innovations, such as trials (DCTs). These developments are expected to have a positive impact on the growth of the risk-based monitoring software industry during the forecast period.

Opportunities

• Launch of new versions of risk-based monitoring software

Key market players are focusing on deploying updated versions of risk-based monitoring software. This could increase the demand for risk-based monitoring software in pharmaceutical companies, biopharmacy companies, CROs, and medical device companies. For instance, in 2018, Bioclinica announced the SMART Technology Suite, which combines medical imaging, electronic data acquisition (EDC), and interactive response technology (IRT).

• Beneficial Factors Associated with the Software

The several beneficial effects of the risk-based monitoring software lead to create more opportunities for the market. Risk-based monitoring software can reduce errors, improve analytics, timely results, and reduce costs.

 Restraints/Challenges

• High Costs

The risk-based monitoring software is definitely helping to outgrow the market size, but one factor limiting the growth is the high price of the software. It is costly, and thus it is not applicable everytime to use it tremendously.

This global risk-based monitoring software market provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global risk-based monitoring software market, contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Risk-Based Monitoring Software Market

The COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to influence on industry growth during the forecast period. Our ongoing research enhances our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included.

COVID19 has significantly increased the demand for medical supplies such as personal protective equipment such as masks, gloves and goggles. As the number of cases of COVID 19 increases worldwide, there is an increasing need for medicines from both medical  professionals and civilians for preventative measures. Manufacturers of these products have the opportunity to take advantage of this growing demand for medical supplies to ensure an adequate and continuous supply of the personal protective equipment market. Given these factors, COVID 19 is expected to impact the risk-based monitoring software market significantly.

Global Risk-Based Monitoring Software Market Scope

The global risk-based monitoring software market is segmented on the basis of type, component, delivery mode, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Enterprise RBM Software
• Site RBM Software

Component

• Software
• Services

Delivery Mode

• Web-Based (On-Demand)
• Licensed Enterprise (On-Premise)
• Cloud-Based (SAAS)

End-User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROS)
• Medical Device Companies
• Other

Risk-Based Monitoring Software Market Regional Analysis/Insights

The global risk-based monitoring software market is analyzed and market size insights and trends are provided by country, type, component, delivery mode, and end-user as referenced above.

The major countries covered in the risk-based monitoring software market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the risk-based monitoring software market due to the increasing number of pharmaceutical companies in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising initiatives and prevalence of funds from government for clinical trials.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Risk-Based Monitoring Software Market Share Analysis

The risk-based monitoring software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to budesonide inhaler system market.

글로벌 위험 기반 모니터링 소프트웨어 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 오라클(미국)
• Medidata Solutions, Inc. (미국)
• Parexel International Corporation. (미국)
• 바이오클리니카(미국)
• Bio-Optronics, Inc. (미국)
• IBM Corporation(미국).
• Veeva Systems (미국)
• DSG, Inc. (미국)
• 마스터컨트롤 주식회사(미국)
• Forte Research Systems India Pvt Ltd(인도)
• Mednet(인도)
• 아리스글로벌 유한책임회사(미국)
• 안주 소프트웨어 주식회사(미국)
• 테크솔 코퍼레이션(미국)
• 오픈클리니카, LLC (미국)
• 시그넌트 헬스(미국)
• Labcorp 약물 개발(미국)

SKU-54222